Get the latest Science News and Discoveries

The Ozempic boom is so massive that US pharmacies have decided to do something unprecedented: start manufacturing it themselves

The 'boom' of new anti-obesity medications is undeniable, brutal, and unprecedented. It's curious because, although I just used three superlative and exaggerated adjectives, I've likely understated it. Ozempic and other GLP-1 agonists have no real precedents, and that's breaking the rules of the game. The Legal Loophole The best example is that, since last year and taking advantage of a small legal clause, hundreds of US pharmacies have been manufacturing and marketing this type of medication without paying a dollar to the patent owners. 2023: The Year of Ozempic The 'Ozempic year'. 2023 was the moment when all these drugs

None

Get the Android app